CN Patent

CN104540822B — 达拉菲尼甲磺酸盐的晶型及其制备方法

Assigned to Hangzhou Ling Ye Pharmaceutical Technology Co Ltd · Expires 2016-08-31 · 10y expired

What this patent protects

本发明涉及达拉菲尼甲磺酸盐的新晶型及其制备方法。本发明所述新晶型具有在水或含水体系中更稳定和水中溶解度、溶出量更大的优点，因此相对于现有的晶型，具有更好的稳定性和生物利用度。

USPTO Abstract

本发明涉及达拉菲尼甲磺酸盐的新晶型及其制备方法。本发明所述新晶型具有在水或含水体系中更稳定和水中溶解度、溶出量更大的优点，因此相对于现有的晶型，具有更好的稳定性和生物利用度。

Drugs covered by this patent

Patent Metadata

Patent number
CN104540822B
Jurisdiction
CN
Classification
—
Expires
2016-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Hangzhou Ling Ye Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.